Management Flashcards
(38 cards)
STEMI Management
NSTEMI Management
Acute LV Failure Management
Tachycardia >125bp, + shock Management
Amiodarone 300mg IV over 20-20mins
Anaphylaxis Management
Acute Exacerbation Asthma/COPD
Add ABx if infective exacerbation
In COPD, hypoxia will kill a lot faster than hypercapnia –> In acute setting, apply high flow then review after an ABG.
If patient not in per-arrest, 28% O2 safer with ABG 30min later to assess affect
Pneumonia Management
Pulmonary Embolism Management
Bacterial meningitis Management
A GP will usually give patients 1.2g benzylpenicillin if there is any suspicion of meningitis.
Status Epilepticus
Ensure airway is patent, recovery position with O2
Status Epilepticus: Seizure lasting more than 30 mins
Stroke Management
If CT shows haemorrhage of any type, refer to neurosurgery, do not give aspirin or thrombolysis
DKA Management
Hypoglycaemia (BM glucose <3 mmol/L) Management
If patient can eat –> sugar rick snack e.g. orange juice, biscuits
If unable to eat (drowsy/vomiting) –> IV glucose 100ml 20% glucose)
Unable to eat and no cannula –> IM glucagon 1mg
Hypertension Management
Lifestyle advice to those with BP > 135/85
Anti-Hypertensives if BP>150/95 or >135/58 + over 8-, CV or renal disease, Diabetes
Target Blood pressure on treatment?
<80yo = aim for <140/90 at clinic
> 80yo = add 10 to systolic values
Chronic Heart Failure Management
- ACEi + B-blocker.
If intolerant of ACEi use ARB
If intolerant of ARB use hydralazine or nitrate - If inadequate, increase dose as tolerated
- If still inadequate add aldosterone receptor antagonist e.g. spironolactone
AF Management
2 Aims of treatment: Prevent stroke + control rhythm and rate of the heart
Rate control: B-blocker + CCB
Stroke Prevention - using CHA2DS2-VASc Score
Congestive Heart failure Hypertension Age > 75 (2 points) Diabetes Mellituse Stroke TIA previous (2 points) Vascular disease (Peripheral arterial disease or IHD) Age 65-74 Sex (female)
Score = 0 –> may not require anticoagulation
1 = consider antigoagulation in men –> DOAC
2 or more = Anticoagulation in men and women –> consider bleeding risk (HAS-BLED)
Bleeding Risk for anticoagulation in AF - Using HAS-BLED score
Hypertension - uncontrolled BP
Abnormal renal function (cr >200/transplant/dialysis. Abnormal liver function (cirrhosis or bilirubin 2x normal, AST/ALT/ALP >3xnormal)
Stroke
Bleeding tendency
Labile INR
Elderly >65yo
Drugs (concomitat aspirin or NSAIDs) or alcohol
0 = low risk bleeding, strongly consider anticoag
1-2 = low-mod risk - consider anticoag
> 3 = high risk - alternatives to anticoags to be considered
stable angina management
GTN spray PRN for symptomatic relief
secondary prev: aspirin, statin, CV RF modification
1 anti-anginal drug: b-blocker, CCB
COPD Management
1) Offer smoking cessation
Offer pneumococcal + influenza vaccinations
Offer pulmonary rehab if indicated
Co-develop personalised self-management plan
2) INHALED THERAPIES: SABA/SAMA
3) No asthmatic features: LABA + LAMA
If symptoms still impacting QOL/experiencing exacerbations: LABA + LAMA + ICS
4) Asthmatic features/responds to steroids: LABA + ICS
If symptoms still impactinf QOL/Exacerbations : LABA + LAMA + ICS
Asthma Management
Type 2 Diabetes: Blood Glucose lowering therapy
Parkinson’s First line Management
Co-beneldopa or co-careldopa
unless very mild disease: Ropinirole (Dopamine agonist) or rasagiline (MAOI)